Table 3.
Metabolic syndrome components in groups at baseline and 16 weeks
| Experimental | Control | |||
|---|---|---|---|---|
| Basal (0 weeks) | Final (16 weeks) | Basal (0 weeks) | Final (16 weeks) | |
| Waist circumference (cm) | 102.7 ± 9.9 | 102.5 ± 10.5 | 98.1 ± 7.0 | 98.8 ± 7.4 |
| Systolic blood pressure (mmHg) | 127.1 ± 11.5a | 122.8 ± 8.5b | 122.4 ± 12.4 | 120.0 ± 13.3 |
| Diastolic blood pressure (mmHg) | 79.7 ± 8.3a | 74.4 ± 5.6b | 80.2 ± 6.6 | 76.4 ± 9.3 |
| Fasting glucose (mg/dL) | 92.7 ± 5.8a | 89.4 ± 7.9b | 88.9 ± 5.8 | 86.9 ± 5.4 |
| HDL cholesterol (mg/dL) | 46.4 ± 10.7 | 46.5 ± 10.8 | 41.2 ± 8.6 | 42.7 ± 14.4 |
| Triglycerides (mg/dL) | 147.5 ± 88.2 | 153.0 ± 98.6 | 179.8 ± 96.5 | 157.4 ± 81.6 |
| Number of positive criteria for metabolic syndrome | 1.84 ± 1.62a | 1.48 ± 1.29b | 1.54 ± 1.13 | 1.54 ± 1.13 |
| Metabolic syndrome prevalence (%) | 32 | 24 | 23 | 23 |
Values are mean ± SD. Student t-test for paired samples was used to analyze differences of means within groups. Student t-test for independent samples was used to analyze differences of means between groups. Wilcoxon signed rank-sum test was used to compare the number of positive criteria for metabolic syndrome. Means within a group with different superscript letters are significantly different; P < 0.05 paired t test